Global Anticoagulant Market Report By Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, And Others), By Route Of Administration (Injectable Anticoagulant And Oral Anticoagulant), By Application (Stroke, Atrial Fibrillation, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026
ID:VMR11211613
February 2020
Report Formats:

The global demand for Anticoagulant Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Anticoagulants, generally called blood thinners, are chemical materials that prohibit or curtail coagulation of blood and lengthen the clotting period. Anticoagulants are used to abolish the chances of blood clots in the body. Blood clots are built when platelets glue together and proteins present in the blood bind together to create a solid lump. Anticoagulants cease the platelets from binding to one another and clotting proteins from adhering together. The market offers various types of anticoagulant drugs, and each drug functions by deterring various paths of blood coagulation. These drugs are primarily used for the high threat of blood clots, deep vein thrombosis, pulmonary embolism, and others. Besides, they are commonly used in the treatment of pulmonary embolism, atrial fibrillation, and managing the risk of stroke.
 
Market Dynamics
 
The global anticoagulants market is anticipated to grow at a substantial rate in the coming years, with the increasing plurality of diseases such as venous thromboembolism and cardiovascular disease across the globe. Moreover, the growing adoption of new oral anticoagulants, and maturing awareness of new techniques is boosting the market growth. Similarly, expanding obesity problems and geriatric population with the growing demand for contemporary therapeutics are predicted to affect the growth of the global anticoagulant market during the forecast period.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of anticoagulant.
 
Market Segmentation
 
The entire anticoagulant market has been sub-categorized into drug class, route of administration and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Drug Class

  • NOACs
  • Heparin & LMWH
  • Vitamin K Antagonist
  • Others
 
By Route Of Administration
  • Injectable Anticoagulant
  • Oral Anticoagulant
 
By Application
  • Stroke
  • Atrial Fibrillation
  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  •  Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for anticoagulant market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Anticoagulant Market By Revenue (USD MN)
 
Europe Anticoagulant Market By Revenue
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the anticoagulant market include Bayer AG, Aspen Holdings, Boehringer Ingelheim GmbH, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, and Portola Pharmaceuticals, Inc., among others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
 
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Anticoagulant Market
       2.2. Global Anticoagulant Market Snapshot
 
3 . ANTICOAGULANT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Anticoagulant Market
       3.3. Market Restraints of Anticoagulant Market
       3.4. Opportunities of Anticoagulant Market
       3.5. Trends of Anticoagulant Market
       3.6. Porter’s Five Force Analysis of Anticoagulant Market
       3.7. Anticoagulant Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Class
           3.7.2 Market Attractive Analysis by Route Of Administration
           3.7.3 Market Attractive Analysis by Application
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Anticoagulant Value Chain Analysis
       4.2. Anticoagulant Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Anticoagulant Raw Material Manufactures List
           4.2.3. Price Trend of Anticoagulant Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY DRUG CLASS
       5.1 Overview by Drug Class
       5.2 Global Anticoagulant Market Analysis by Drug Class
       5.3 Market Analysis of NOACs by Regions
       5.4 Market Analysis of Heparin & LMWH by Regions
       5.5 Market Analysis of Vitamin K Antagonist by Regions
       5.6 Market Analysis of Others by Regions
 
6 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       6.1 Overview by Route Of Administration
       6.2 Global Anticoagulant Market Analysis by Route Of Administration
       6.3 Market Analysis of Injectable Anticoagulant by Regions
       6.4 Market Analysis of Oral Anticoagulant by Regions
 
7 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Global Anticoagulant Market Analysis by Application
       7.3 Market Analysis of Stroke by Regions
       7.4 Market Analysis of Atrial Fibrillation by Regions
       7.5 Market Analysis of Pulmonary Embolism (PE) by Regions
       7.6 Market Analysis of Deep Vein Thrombosis (DVT) by Regions
       7.7 Market Analysis of Others by Regions
 
8 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Anticoagulant Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Anticoagulant Market Estimate by Market Segment
           8.4.3. Europe Anticoagulant Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Anticoagulant Market Estimate by Market Segment
           8.5.3. Asia Pacific Anticoagulant Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Anticoagulant Market Estimate by Market Segment
           8.6.3. Latin America Anticoagulant Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Anticoagulant Market Estimate by Market Segment
           8.7.3. Middle East & Africa Anticoagulant Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE ANTICOAGULANT COMPANIES
       9.1. Anticoagulant Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ANTICOAGULANT INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Bayer AG
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Aspen Holdings
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Boehringer Ingelheim GmbH
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Daiichi Sankyo Company, Limited
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Bristol-Myers Squibb Company
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. GlaxoSmithKline
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Pfizer, Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Sanofi S.A.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Johnson & Johnson
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Portola Pharmaceuticals, Inc.
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Anticoagulant Market Snapshot
  • Drivers of The Global Anticoagulant Market Impact Analysis
  • Restraints of The Global Anticoagulant Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Anticoagulant Market Analysis by Drug Class (USD MN)
  • Global Anticoagulant Market Analysis in NOACs by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Heparin & LMWH by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Vitamin K Antagonist by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Route Of Administration (USD MN)
  • Global Anticoagulant Market Analysis in Injectable Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Oral Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Application (USD MN)
  • Global Anticoagulant Market Analysis in Stroke by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Atrial Fibrillation by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Pulmonary Embolism (PE) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Deep Vein Thrombosis (DVT) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Global Anticoagulant Market by Geography (USD MN)
  • North America Anticoagulant Market Analysis by Drug Class (USD MN)
  • North America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • North America Anticoagulant Market Estimate by Application (USD MN)
  • North America Anticoagulant Market Estimate by Country (USD MN)
  • United State Anticoagulant Market Analysis by Drug Class (USD MN)
  • United State Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • United State Anticoagulant Market Analysis by Application (USD MN)
  • Rest of North America Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of North America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of North America Anticoagulant Market Estimate by Application(USD MN)
  • Europe Anticoagulant Market Analysis by Drug Class (USD MN)
  • Europe Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Europe Anticoagulant Market Estimate by Application (USD MN)
  • United Kingdom Anticoagulant Market Analysis by Drug Class (USD MN)
  • United Kingdom Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • United Kingdom Anticoagulant Market Estimate by Application (USD MN)
  • France Anticoagulant Market Analysis by Drug Class (USD MN)
  • France Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • France Anticoagulant Market Estimate by Application (USD MN)
  • Germany Anticoagulant Market Analysis by Drug Class (USD MN)
  • Germany Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Germany Anticoagulant Market Estimate by Application (USD MN)
  • Rest of Europe Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of Europe Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of Europe Anticoagulant Market Estimate by Application (USD MN)
  • Asia Pacific Anticoagulant Market Analysis by Drug Class (USD MN)
  • Asia Pacific Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Asia Pacific Anticoagulant Market Estimate by Application (USD MN)
  • Asia Pacific Anticoagulant Market Estimate by Country (USD MN)
  • China Anticoagulant Market Analysis by Drug Class (USD MN)
  • China Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • China Anticoagulant Market Estimate by Application (USD MN)
  • Japan Anticoagulant Market Analysis by Drug Class (USD MN)
  • Japan Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Japan Anticoagulant Market Estimate by Application (USD MN)
  • India Anticoagulant Market Analysis by Drug Class (USD MN)
  • India Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • India Anticoagulant Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of Asia Pacific Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of Asia Pacific Anticoagulant Market Estimate by Application (USD MN)
  • Latin America Anticoagulant Market Analysis by Drug Class (USD MN)
  • Latin America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Latin America Anticoagulant Market Estimate by Application (USD MN)
  • Latin America Anticoagulant Market Estimate by Country (USD MN)
  • Brazil Anticoagulant Market Analysis by Drug Class (USD MN)
  • Brazil Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Brazil Anticoagulant Market Estimate by Application (USD MN)
  • Rest of Latin America Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of Latin America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of Latin America Anticoagulant Market Estimate by Application (USD MN)
  • Middle East & Africa Anticoagulant Market Analysis by Drug Class (USD MN)
  • Middle East & Africa Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Middle East & Africa Anticoagulant Market Estimate by Application (USD MN)
  • Middle East & Africa Anticoagulant Market Estimate by Country (USD MN)
  • Middle East Anticoagulant Market Analysis by Drug Class (USD MN)
  • Middle East Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Middle East Anticoagulant Market Estimate by Application (USD MN)
  • Africa Anticoagulant Market Analysis by Drug Class (USD MN)
  • Africa Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Africa Anticoagulant Market Estimate by Application (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Anticoagulant Report
  • Market Research Process
  • Market Research Methodology
  • Global Anticoagulant Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Anticoagulant Market Analysis by Drug Class (USD MN)
  • Global Anticoagulant Market Analysis in NOACs by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Heparin & LMWH by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Vitamin K Antagonist by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Route Of Administration (USD MN)
  • Global Anticoagulant Market Analysis in Injectable Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Oral Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Application (USD MN)
  • Global Anticoagulant Market Analysis in Stroke by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Atrial Fibrillation by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Pulmonary Embolism (PE) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Deep Vein Thrombosis (DVT) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Latin America Anticoagulant Market by Revenue
  • Middle East & Africa Anticoagulant Market by Revenue
  • Recent Development in Anticoagulant Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials